Evidence map›Paper›PMID 34739165›Full record

ReviewHuman psychopharmacology2022

Potential processes of change in MDMA-Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self-transcendence, and therapeutic relationships.

Jason B Luoma, Ben Shahar, M Kati Lear, Brian Pilecki, Anne Wagner

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Human psychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05138068 (Social Anxiety MDMA-Assisted Therapy Investigation), which is not on this map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05138068 phase2completednot on this map

Social Anxiety MDMA-Assisted Therapy Investigation (SAMATI): A Randomized, Delayed Treatment Control Phase 2 Study of the Safety and Effectiveness of Manualized MDMA-Assisted Therapy for the Treatment of Social Anxiety Disorder

TypeinterventionalSponsorJason B LuomaRan2022 to 2025Enrolled90ConditionsSocial Anxiety DisorderArmsMDMA, Psychotherapy
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Jason B LuomaPortland Psychotherapy Clinic, Research, & Training Center, Portland, Oregon, USA.ORCID 0000-0002-3601-7037
Ben ShaharThe Hebrew University of Jerusalem, Jerusalem, Israel.
M Kati LearPortland Psychotherapy Clinic, Research, & Training Center, Portland, Oregon, USA.
Brian PileckiPortland Psychotherapy Clinic, Research, & Training Center, Portland, Oregon, USA.
Anne WagnerRemedy Centre, Toronto, Ontario, Canada.
Oregon Clinic · USHebrew University of Jerusalem · ILOccupational Cancer Research Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveResearchers have suggested that psychotherapy may be enhanced by the addition of 3,4-methylenedioxymethamphetamine (MDMA), particularly in the treatment of disorders wherein interpersonal dysfunction is central, such as social anxiety disorder. We review literature pertaining to three potential processes of change that may be instigated during sessions involving MDMA administration in the treatment of social anxiety disorder.

designThis is a narrative review that integrates research on the etiology and maintenance of social anxiety disorder and mechanisms of action of MDMA to examine how MDMA may enhance psychotherapy outcomes.

resultsWe first outline how MDMA may enhance memory reconsolidation in social anxiety disorder. We then discuss how MDMA may induce experiences of self-transcendence and self-transcendent emotions such as compassion, love, and awe; and how these experiences may be therapeutic in the context of social anxiety disorder. We subsequently discuss the possibility that MDMA may enhance the strength and effectiveness of the therapeutic relationship which is a robust predictor of outcomes across many disorders as well as a potential key ingredient in treating disorders where shame and social disconnection are central factors.

conclusionWe discuss how processes of change may extend beyond the MDMA dosing sessions themselves.

Indexed as

N-Methyl-3,4-methylenedioxyamphetaminePhobia, SocialEmotionsEmpathyHumansPsychotherapyN-Methyl-3,4-methylenedioxyamphetamineMDMAmemory reconsolidationprocesses of changeself-transcendencesocial anxiety disordertherapeutic relationship

Identifiers

PMID34739165
PMCPMC9285360
OpenAlexW3209897178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.